Editorial policy

Every Peptide Studio article breaks a claim into small, checkable pieces. These rules decide what counts as a piece of evidence and how it is reported.

Evidence is named

A claim says whether it rests on an approved label, a human trial, an animal model or a cell experiment, and what that kind of study cannot show. Results in rodents are never written up as results in people.

Sources

The 27 longer articles were fact-checked against PubMed and PubMed Central records, ClinicalTrials.gov, FDA labels and DailyMed, regulator notices from the US, Canada and Europe, anti-doping bodies and established medical and trade news. Their sources are linked under each article. The 12 shorter introductory articles are general explainers; since November 2026 each one links the papers, labels and official pages behind its facts in the text and lists them under it. Seller pages, clinic marketing and forums are not used as evidence.

Doses

Some titles name dosage because that is what people search for. The answer is always what studies used, what labels state and, for anything unapproved, the plain fact that no human dose has been established. There is no personal dosing advice, no schedule for self-use, no injection site and no conversion of a human dose into syringe units.

Independence

No advertisers, sponsors or affiliate links, and no seller is ever named as a place to buy. Articles appear under the Peptide Studio editors name; the site does not invent bylines or credentials.

Corrections

Confirmed errors are fixed in the article, and a "Last reviewed" date appears after a real edit. Report errors on the contact page with the record you checked.

Last updated 3 Nov 2026. See also the editorial policy, privacy policy and about page.